Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05861362Not ApplicableCompleted

Feasibility and Metabolic Effects of a 5:2 Fasting Intervention in Women With Breast Cancer During Radiotherapy

Role: lead

NCT02516501Not ApplicableCompleted

Impact of a Ketogenic Diet Intervention During Radiotherapy on Body Composition

Role: lead

NCT04264455Unknown

Evaluation of Long-term Incidence of Ventricular Arrhythmias in Patients With Acute Myocarditis

Role: collaborator

NCT04574323Not ApplicableCompleted

Effects of a Paleolithic Lifestyle Intervention in Breast Cancer Patients Undergoing Radiotherapy

Role: lead

All 4 trials loaded